MPO and COVID-19: Based on current evidence, there are two more pediatric cases of patients aged 12 and 17 years old respectively, with MPO-ANCA vasculitis following COVID-19 presenting two months later with diffuse alveolar hemorrhage and acute kidney injury possibly as a subsequent postinfectious development of anti-MPO vasculitis [6,8].